283 related articles for article (PubMed ID: 27272353)
1. Quality Control and Complication Screening Programme of Chinese Medicinal Drugs at the First German Hospital of Traditional Chinese Medicine - A Retrospective Analysis.
Melchart D; Hager S; Dai J; Weidenhammer W
Forsch Komplementmed; 2016; 23 Suppl 2():21-8. PubMed ID: 27272353
[TBL] [Abstract][Full Text] [Related]
2. [Establishment and application of "multi-dimensional structure and process dynamic quality control technology system" in preparation products of traditional Chinese medicine (I)].
Gu JF; Feng L; Zhang MH; Wu C; Jia XB
Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(21):3613-7. PubMed ID: 24494541
[TBL] [Abstract][Full Text] [Related]
3. New Analytical Monographs on TCM Herbal Drugs for Quality Proof.
Wagner H; Bauer R; Melchart D
Forsch Komplementmed; 2016; 23 Suppl 2():16-20. PubMed ID: 27271998
[TBL] [Abstract][Full Text] [Related]
4. Modern European monographs for quality control of Chinese herbs.
Bauer R; Franz G
Planta Med; 2010 Dec; 76(17):2004-11. PubMed ID: 21077026
[TBL] [Abstract][Full Text] [Related]
5. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials.
Cheng CW; Bian ZX; Li YP; Moher D; Wu TX; Dagenais S; Li J; Li TQ
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):881-6. PubMed ID: 18782527
[TBL] [Abstract][Full Text] [Related]
6. [Development of quality traceability system of traditional Chinese medicine].
Cai Y; Hu H; Ni JY; Wang YT
Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(22):3829-33. PubMed ID: 24558859
[TBL] [Abstract][Full Text] [Related]
7. [Significance of re-evaluation and development of Chinese herbal drugs].
Gao Y; Ma Z; Zhang B
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):1-4. PubMed ID: 22741451
[TBL] [Abstract][Full Text] [Related]
8. Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases.
Teschke R; Zhang L; Long H; Schwarzenboeck A; Schmidt-Taenzer W; Genthner A; Wolff A; Frenzel C; Schulze J; Eickhoff A
Ann Hepatol; 2015; 14(1):7-19. PubMed ID: 25536637
[TBL] [Abstract][Full Text] [Related]
9. Quality markers based on biological activity: A new strategy for the quality control of traditional Chinese medicine.
Wu X; Zhang H; Fan S; Zhang Y; Yang Z; Fan S; Zhuang P; Zhang Y
Phytomedicine; 2018 May; 44():103-108. PubMed ID: 29506773
[TBL] [Abstract][Full Text] [Related]
10. [Development of Chinese herbal pieces and analysis of problems of total quality management].
Wang J; Qiao XY; Lin F; Chen YF
Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4475-8. PubMed ID: 25850288
[TBL] [Abstract][Full Text] [Related]
11. [Quality and safety of Chinese medicine drugs in Germany - an update].
Hempen N; Huber R
Forsch Komplementmed; 2014; 21(6):401-12. PubMed ID: 25592951
[TBL] [Abstract][Full Text] [Related]
12. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
[TBL] [Abstract][Full Text] [Related]
13. [Safety research in Chinese medicines based on application of data mining].
Tong Y; Yang J; Li C; He W
Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):3047-50. PubMed ID: 22308699
[TBL] [Abstract][Full Text] [Related]
14. [Influence factors of hepatotoxicity of traditional Chinese medicine preparation products based on multidimensional structure dynamic process].
Liu Y; Wang G; Zhong QX; Wu H; Song J; Feng L; Jia XB
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3031-3035. PubMed ID: 29171217
[TBL] [Abstract][Full Text] [Related]
15. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections].
Jiang JJ; Xie YM
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909
[TBL] [Abstract][Full Text] [Related]
16. [Influence factors for hepatotoxicity of traditional Chinese medicine preparations].
Liu Y; Wang G; Zhong QX; Wu H; Song J; Feng L; Jia XB
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3049-3055. PubMed ID: 29171220
[TBL] [Abstract][Full Text] [Related]
17. Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs.
Koh HL; Woo SO
Drug Saf; 2000 Nov; 23(5):351-62. PubMed ID: 11085343
[TBL] [Abstract][Full Text] [Related]
18. [Suggestions for improving quality control of extrinsic residues in crude drugs].
Zhao Y; Qian Z
Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(19):2741-3. PubMed ID: 22242440
[TBL] [Abstract][Full Text] [Related]
19. [Problems in medicinal materials research of new traditional Chinese medicine].
Zhou G; Wang T; He YP
Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):3192-5. PubMed ID: 25509314
[TBL] [Abstract][Full Text] [Related]
20. From quality markers to data mining and intelligence assessment: A smart quality-evaluation strategy for traditional Chinese medicine based on quality markers.
Bai G; Zhang T; Hou Y; Ding G; Jiang M; Luo G
Phytomedicine; 2018 May; 44():109-116. PubMed ID: 29426601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
